KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Prepaid Assets: 2017-2024

Historic Prepaid Assets for Moderna (MRNA) over the last 8 years, with Dec 2024 value amounting to $599.0 million.

  • Moderna's Prepaid Assets fell 13.00% to $716.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $716.0 million, marking a year-over-year decrease of 13.00%. This contributed to the annual value of $599.0 million for FY2024, which is 4.47% down from last year.
  • Moderna's Prepaid Assets amounted to $599.0 million in FY2024, which was down 4.47% from $627.0 million recorded in FY2023.
  • Over the past 5 years, Moderna's Prepaid Assets peaked at $1.2 billion during FY2022, and registered a low of $252.0 million during FY2020.
  • Its 3-year average for Prepaid Assets is $807.0 million, with a median of $627.0 million in 2023.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 1,198.77% in 2020, then slumped by 47.53% in 2023.
  • Over the past 5 years, Moderna's Prepaid Assets (Yearly) stood at $252.0 million in 2020, then skyrocketed by 188.89% to $728.0 million in 2021, then soared by 64.15% to $1.2 billion in 2022, then slumped by 47.53% to $627.0 million in 2023, then decreased by 4.47% to $599.0 million in 2024.